Dissociation between Corneal and Cardiometabolic Changes in Response to a Time-Restricted Feeding of a High Fat Diet
- PMID: 35011018
- PMCID: PMC8746991
- DOI: 10.3390/nu14010139
Dissociation between Corneal and Cardiometabolic Changes in Response to a Time-Restricted Feeding of a High Fat Diet
Abstract
Mice fed a high fat diet (HFD) ab libitum show corneal dysregulation, as evidenced by decreased sensitivity and impaired wound healing. Time-restricted (TR) feeding can effectively mitigate the cardiometabolic effects of an HFD. To determine if TR feeding attenuates HFD-induced corneal dysregulation, this study evaluated 6-week-old C57BL/6 mice fed an ad libitum normal diet (ND), an ad libitum HFD, or a time-restricted (TR) HFD for 10 days. Corneal sensitivity was measured using a Cochet-Bonnet aesthesiometer. A corneal epithelial abrasion wound was created, and wound closure was monitored for 30 h. Neutrophil and platelet recruitment were assessed by immunofluorescence microscopy. TR HFD fed mice gained less weight (p < 0.0001), had less visceral fat (p = 0.015), and had reduced numbers of adipose tissue macrophages and T cells (p < 0.05) compared to ad libitum HFD fed mice. Corneal sensitivity was reduced in ad libitum HFD and TR HFD fed mice compared to ad libitum ND fed mice (p < 0.0001). Following epithelial abrasion, corneal wound closure was delayed (~6 h), and neutrophil and platelet recruitment was dysregulated similarly in ad libitum and TR HFD fed mice. TR HFD feeding appears to mitigate adipose tissue inflammation and adiposity, while the cornea remains sensitive to the pathologic effects of HFD feeding.
Keywords: corneal dysregulation; high fat diet; neutrophils; obesity; platelets; time-restricted feeding.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Ginsberg H.N., Maccallum P.R. The Obesity, Metabolic Syndrome, and Type 2 Diabetes Mellitus Pandemic: Part I. Increased Cardiovascular Disease Risk and the Importance of Atherogenic Dyslipidemia in Persons With the Metabolic Syndrome and Type 2 Diabetes Mellitus. J. Cardiometabolic Syndr. 2009;4:113–119. doi: 10.1111/j.1559-4572.2008.00044.x. - DOI - PMC - PubMed
-
- World Health Organization Obesity and Overweight. [(accessed on 6 August 2021)]; Available online: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
-
- Hales C.M., Carroll M.D., Fryar C.D., Ogden C.L. Prevalence of Obesity and Severe Obesity among Adults: United States, 2017–2018. CDC National Center for Health Statistics; Hyattsville, MD, USA: 2020. pp. 1–8.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
